Navigation Links
HeartWare Reports Second Quarter 2012 Results
Date:8/7/2012

tion therapy from the FDA," added Mr. Godshall.  "Our second quarter results also reflect increased investment in our technology pipeline, particularly our MVAD® System for which human clinical testing is expected this year, as well as ramping of personnel in anticipation of expanded commercialization."

Total operating expenses for the second quarter of 2012 were $34.2 million, as compared to $20.2 million in the same period of 2011.  Research and development expense was $20.0 million for the second quarter of 2012, as compared to $10.3 million in the same period of 2011, primarily attributable to the Company's continuing clinical trial costs and research and development costs related to advancing HeartWare's pipeline technologies.  Selling, general and administrative expenses were $14.2 million in the second quarter of 2012, compared to $9.9 million in the second quarter of 2011.  The increase in selling, general and administrative expenses is related to a higher volume of commercial activity outside of the U.S. and an enhanced corporate infrastructure to support overall growth and anticipated commercialization in the U.S.

Net loss for the second quarter of 2012 was $22.8 million, or a $1.61 loss per basic and diluted share, compared to a $10.1 million net loss, or a loss of $0.73 per basic and diluted share, in the second quarter of 2011.  For the six months ended June 30, 2012, the Company recorded a net loss of $41.6 million, or a $2.94 loss per basic and diluted share, compared to a $19.5 million net loss, or a loss of $1.40 per basic and diluted share, in the first half of 2011.

At June 30, 2012, the Company had $131.0 million of cash, cash equivalents and investments, as compared to $144.5 million at March 31, 2012 and $163.2 million at December 31, 2011.

HeartWare will host a conference call on Tuesday, August 7, 2012 at 5:00 p.m. U.S. Eastern Daylight Time (being 7:00 a.m. Australian Ea
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. HeartWare Completes Acquisition Of World Heart Corporation
2. HeartWare Schedules Second Quarter Conference Call And Webcast
3. HeartWare Names Peter F. McAree Chief Financial Officer
4. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
5. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
6. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
7. Heartware Schedules First Quarter Conference Call And Webcast
8. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Express Scripts Reports Second Quarter Results
11. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015  The recent flurry of PBM ... employer groups scrambling to identify a pharmacy benefit ... care plan, retail pharmacy chain, or other potentially ... purchase of Catamaran, Rite Aid,s $2 billion acquisition ... Omni-Care for $10 billion are just the latest ...
(Date:5/28/2015)... May 28, 2015 The Federal Trade ... antitrust suit charging Cephalon, Inc. with illegally blocking ... The settlement ensures that Teva Pharmaceutical Industries, Ltd., ... total of $1.2 billion available to compensate purchasers, ... because of Cephalon,s illegal conduct.  ...
(Date:5/28/2015)... , May 28, 2015 Lungpacer Medical, ... catheter-based phrenic-nerve-pacing system announced today that it will ... Conference on Thursday, June 4, 2015 in New ... 11:30 a.m. Eastern Time.   About ... a preclinical stage medical device company pioneering the ...
Breaking Medicine Technology:Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 2FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 3
... Conn., Sept. 23, 2011 Butrans® (Buprenorphine) Transdermal System ... pain over the last 24 hours" scores compared to ... moderate-to-severe chronic low back pain , according to ... online, August issue of The Journal of Pain ...
... 2011 Take Care Health Systems, a wholly-owned subsidiary ... Sanofi US today announced the opening of a full-service ... in Bridgewater, New Jersey. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO) ... dedicated to solving health challenges, it is essential for ...
Cached Medicine Technology:Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain 2Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain 3Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain 4Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain 5Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain 6Walgreens Take Care Health Systems and Sanofi US Open On-site Medical Center and Pharmacy 2Walgreens Take Care Health Systems and Sanofi US Open On-site Medical Center and Pharmacy 3Walgreens Take Care Health Systems and Sanofi US Open On-site Medical Center and Pharmacy 4Walgreens Take Care Health Systems and Sanofi US Open On-site Medical Center and Pharmacy 5
(Date:5/28/2015)... NY (PRWEB) May 28, 2015 The ... Care are proud to present Dr. Alicia Almendral as ... be a big part of the newly opened facility’s ... finest in modern cosmetic treatments. , Dr. Almendral is ... in the latest anti-aging and cosmetic enhancement techniques. Her ...
(Date:5/28/2015)... Los Angeles, Calif. (PRWEB) May 28, 2015 ... announces its selection by ContentChecked (CNCK) as its ... ContentChecked’s latest health and nutrition app, SugarChecked. SugarChecked ... consumers to better understand the potential sugars they ... be responsible for the launch of SugarChecked, execute ...
(Date:5/28/2015)... Success Strategies for Biosimilars Approval:, ... Webinar**, June 23, 2015 — 11:00 a.m. – ... June 23, 2015, FDAnews is offering the combined ... attorneys from the international law firm Duane Morris ... A Roadmap to the 351(k) Application Process. , ...
(Date:5/28/2015)... 2015 Park Cities Pet Sitter is offering ... class starting Saturday, June 6th at 10:30am. The ... McCommas Blvd in Dallas, with a maximum of six dogs ... five weeks, with no class being held over the 4th ... , In this Intermediate-to-Advanced level class, dogs will solidify their ...
(Date:5/28/2015)... 28, 2015 The Boys & Girls Club ... Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) ... the club can receive much more support as play begins ... A former Boys & Girls Club member and volunteer with ... Ms. Gulbis has accepted the Horizon Blue Cross Blue Shield ...
Breaking Medicine News(10 mins):Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:ContentChecked Selects PMBC Group To Launch New Nutrition App SugarChecked 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3
... Healthy City has raised concern over the high prevalence ... specially females, lower socio-economic and indigenous groups.//,Smoking, which still ... has the dubious distinction of affecting all the systems ... the Shanghai Municipal Center for Disease Prevention and Control ...
... artificial sweeteners got an impetus when a new study ... rat study conducted by Italy’s Ramazzini Institute //is totally ... conducted on aspartame. The U.S. Food & Drug Administration ... in the use of aspartame. The study, to be ...
... that the company is conducting various studies to start producing ... is high worldwide which may lead to a high shortage ... South Africa. ,The South African authorities feel that ... the maximum worldwide production of bird flu vaccines would be ...
... the UK after a successful bypass surgery in Delhi at ... medical tourism.// ,Mavis Childs, 67, waited for more than ... Service (NHS). But she opted for India when the operation ... pain., ,Childs, based in Wombourne, near Wolverhampton, says she ...
... issue of the Journal of the American Geriatrics Society, ... their incidence of falls if they take a vitamin ... vitamin D supplementation can reduce the incidence of falls ... are not classically vitamin D deficient, the Australian researchers ...
... this week’s Australian Medical Journal (AMA) has found that first-time ... of complications if they choose to deliver naturally in subsequent ... The study has found women who have a ... uterine ruptures during birth, post-partum bleeding, infection and hysterectomies than ...
Cached Medicine News:Health News:Aspartame, Artificial Sweetener, A Safe Bet! 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 3Health News:British Grandmother has timely bypass surgery in India 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: